[Treatment of acute arterial obliterations of the limbs].
D000208:Acute Disease; D000367:Age Factors; D000671:Amputation, Surgical; D000783:Aneurysm / Q000150:complications; D000792:Angiography; D001132:Arm / Q000098:blood supply*; D003911:Dextrans / Q000008:administration & dosage; D004617:Embolism / Q000175:diagnosis / Q000209:etiology; D005260:Female; D005263:Femoral Artery; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007083:Iliac Artery; D007511:Ischemia; D007866:Leg / Q000098:blood supply*; D008297:Male; D011150:Popliteal Artery; D011379:Prognosis; D013300:Streptokinase / Q000627:therapeutic use; D013923:Thromboembolism / Q000601:surgery*; D013927:Thrombosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D014665:Vasodilator Agents / Q000008:administration & dosage
D003911:Dextrans; D005343:Fibrinolytic Agents; D014665:Vasodilator Agents; D006493:Heparin; D013300:Streptokinase
Traitement des oblitérations artérielles aiguës des membres.